Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Caleb Norton

Cardiovascular Disease Saint Louis, MO Medical Doctor

NPI 1447782800 CMS profile 7731054

10012 Kennerly Rd Ste 202, Ste 202, Saint Louis, MO 63128

Open in the dashboard

General payments

$40,071

198 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Caleb Norton of Saint Louis, MO is reported in the CMS Open Payments database as having received $40,071 across 198 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,555 67
2024 General $14,570 66
2023 General $18,076 41
2022 General $1,870 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Caleb Norton
  • Cardiovascular Disease median
  • Middle half of Cardiovascular Disease
  • National median

In program year 2025, general payments to Caleb Norton were reported at $5,555. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.

Show as a table
Year Caleb Norton Cardiovascular Disease median Middle half National median
2019 $0 $450 $127–$1,392 $163
2020 $0 $242 $77–$751 $114
2021 $0 $335 $101–$1,037 $132
2022 $1,870 $395 $121–$1,211 $149
2023 $18,076 $443 $136–$1,283 $160
2024 $14,570 $450 $136–$1,323 $164
2025 $5,555 $432 $132–$1,252 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Abbott Laboratories $15,177 44 payments
  2. Medtronic, Inc. $13,428 91 payments
  3. Boston Scientific Corporation $9,117 29 payments
  4. Biosense Webster, Inc. $1,699 23 payments
  5. Biotronik Inc. $248 4 payments
  6. Cardiovascular Systems Inc. $133 1 payment
  7. Cardiva Medical, Inc. $96 1 payment
  8. Stereotaxis Inc $84 1 payment
  9. Impulse Dynamics (USA) Inc. $30 1 payment
  10. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $25 1 payment
  11. Other $34 2 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Grant $25,090 8 payments
  2. Food and Beverage $8,908 152 payments
  3. Travel and Lodging $5,363 33 payments
  4. Education $626 4 payments
  5. Entertainment $84 1 payment
Products named General payments · program years 2022–2025
  1. Micra $1,512 23 payments
  2. Carto 3 $1,183 15 payments
  3. ENSITE Electrophysiology $1,122 11 payments
  4. General - Therapies $855 5 payments
  5. AURORA EV-ICD MRI SURESCAN $448 8 payments
  6. ENSITE Structural Heart $446 4 payments
  7. ARCTIC FRONT ADVANCE $359 4 payments
  8. QDOT MICRO $348 5 payments
  9. COBALT DR MRI SURESCAN $283 6 payments
  10. Acticor 7 VR-T DX $236 3 payments
  11. Other $2,053 59 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

198 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Cardiovascular Disease in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record